𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region

✍ Scribed by Ulrich Hauser; Vera Balz; Thomas E. Carey; Reidar Grénman; Anke van Lierop; Kathrin Scheckenbach; Henning Bier

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
89 KB
Volume
24
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Background:

Aberrations of the p53 tumor suppressor gene are common events in squamous cell carcinomas of the head and neck (scchn). however, reported frequencies range considerably, and the predictive value of aberrant p53 is continuing to be an issue of controversy. these inconsistencies are possibly caused by methodical limitations.

Methods:

In cell lines established from 23 scchn, we performed sequence analysis of p53 mrna and genomic dna, as well as protein detection using immunohistochemistry and western blotting.

Results:

Of the 23 scchn, 21 (91%) tumors have aberrant or no p53, including four aberrations (19%) located outside the usually examined exons 5 to 9. a second allele is present in 11, and the respective transcript in 4 tumors. expression of protein could be detected in only 12 of the 21 p53 aberrant tumors (57%).

Conclusions:

Depending on the methodical approach applied, a considerable number of scchn may be misclassified regarding their p53 status.

📜 SIMILAR VOLUMES

Functional characterization of p53 molec
Functional characterization of p53 molecules expressed in human squamous cell carcinomas of the head and neck
✍ W. Andrew Yeudall; Judit Jakus; John F. Ensley; Keith C. Robbins 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

Mutation of the p53 tumor suppressor gene has been demonstrated in a large proportion of human head and neck squamous cell carcinomas (HNSCCs) and has been assumed to play a role in the pathogenesis of these tumors, although no formal evidence of functional aberration has been demonstrated. In this

Abnormalities in the p53 gene in tumors
Abnormalities in the p53 gene in tumors and cell lines of human squamous-cell carcinomas of the head and neck
✍ Xiao-Ying Yin; Martin L. Smith; Theresa L. Whiteside; Joseph Locker; Jonas T. Jo 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 943 KB

Abnormalities in the p53 gene were studied in a series of cell lines of human squamous-cell carcinoma of the head and neck (SCCHN) and in tumor tissues. Restriction-fragment-length polymorphism (RFLP), quantitative hybridization and immunochemical analysis of mutant p53 proteins were combined to det

Functional characterization in vivo of m
Functional characterization in vivo of mutant p53 molecules derived from squamous cell carcinomas of the head and neck
✍ Massimo Cardinali; F. James Kratochvil; John F. Ensley; Keith C. Robbins; W. And 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB 👁 2 views

Loss of wild-type p53, either through deletion or mutation, has been demonstrated in most squamous cell carcinomas of the head and neck (HNSCC). Whether these mutant molecules contribute to tumor progression purely through loss of wild-type functions or by growth-promoting mechanisms, however, remai

Mutational analysis of the PTEN gene in
Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma
✍ Xiyun Shao; Raj Tandon; Ghassan Samara; Hiroaki Kanki; Hiroko Yano; Lanny G. Clo 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 121 KB 👁 2 views

## Loss of heterozygosity (LOH ) at chromosome band 10q23 occurs frequently in a wide variety of human tumors. A recently identified candidate tumor suppressor gene, PTEN located on 10q23, is mutated in multiple advanced cancers. To explore whether PTEN is associated with human squamous cell carci

Studies of cellular retinol-binding prot
Studies of cellular retinol-binding protein (CRBP) in squamous-cell carcinomas of the head and neck region
✍ G. Fex; P. Wahlberg; A. Biörklund; J. Wennerberg; R. Willén 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 French ⚖ 512 KB

Cellular retinol-binding protein (CRBP) concentration was determined by radioimmunoassay in biopsies from normal mucosa and squamous-cell cancers of the head and neck region in 26 patients. The plasma concentrations of retinol, retinol-binding protein (REP), prealbumin, albumin, orosomucoid and alfa